Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...
Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
7d
New Scientist on MSNCAR T-cells enable record-breaking 18-year nerve cancer remissionA person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...
CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...
CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.
Therapy timing, patient factors, and emerging combination interventions are guiding treatment decisions in multiple myeloma and lymphoma.
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following ...
An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...
Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and ...
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results